Table 2.

Correlation between clinical markers and DNA methylation in Alzheimer Disease subjects (n=43).

		ALU	LINE-1	SAT-α
CSF β-amyloid	Beta*	0.000	-0.002	0.004
	SE	0.000	0.001	0.847
	p-value	0.948	0.07	0.406
CSF TAU-total	Beta*	0.000	0.000	0.000
	SE	0.000	0.000	0.002
	p-value	0.579	0.370	0.879
CSF TAU-phosporilated	Beta*	0.000	0.000	0.002
	SE	0.003	0.007	0.029
	p-value	0.939	0.996	0.936

^*Beta are regression coefficients from linear regression, expressing the size of methylation change associated with the independent variable.